Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Board Meeting
|
Strong Performer, Under Radar
1197.1000
8.90
(
0.75
%)
NSE
May 23, 2025
15:31 PM
Volume:
395.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
13 Feb 2024
Board Meeting
1197.10
0.75%
Aurobindo Pharma (HOLD): Strong margin uptick
Hold:
Aurobindo Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1100
Target
BOB Capital Markets Ltd.
Q3 EBITDA/PAT surged 68%/90% YoY led by growth in US/EM revenue and ~700bps jump in operating margin
Aurobindo Pharma Ltd. is trading
below its 150 day SMA
of 1221.4
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - May 23, 2025
The Baseline |
23 May 2025, 05:22PM
Market closes higher, BEML's Q4 net profit grows 12% YoY to Rs 287.6 crore
Trendlyne Marketwatch |
23 May 2025, 04:07PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020